ArticleClinical ophthalmology (Auckland, N.Z.)2015

Intravitreal ranibizumab as a primary or a combined treatment for severe retinopathy of prematurity.

Odalis Arámbulo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.